More Articles
The FDA has announced that Oscor, a Florida-based healthcare technology company focused on cardiac care solutions, is recalling 14 lots of its Destino Twist 14F and Guidestar 14F steerable guiding sheaths.
…
Patients treated for a transient ischemic attack (TIA) or minor ischemic stroke (mIS) do not face a higher risk of subsequent stroke if treated at a…
Robocath, a French healthcare technology company focused on designing robotic solutions that can treat vascular diseases, has completed a clinical study of its R-One robotic assistance…
The FDA has announced that Cardiovascular Systems is recalling its Wirion embolic protection device due to issues with the filter breaking off during the retrieval process. The recall covers a total of 697 devices. …
One month of dual antiplatelet therapy (DAPT) followed by standard antiplatelet therapy (SAPT) may be a safe and effective treatment option for patients after percutaneous intervention (PCI), according to…
The distal transradial approach (dTRA) may offer certain improvements over a conventional transradial approach (TRA) during coronary interventions, according to new findings published in JACC: Cardiovascular Interventions. …
Women with premature atherosclerotic cardiovascular disease (ASCVD) are more inclined to report poorer overall physical and mental health—as well as an…
Recent marijuana users are more than twice as likely to develop a dangerous bleeding complication after an aneurysmal subarachnoid hemorrhage (aSAH), according to new data published in Stroke.…
Sildenafil, a popular medication used to treat erectile dysfunction, may increase the severity of abdominal aortic aneurysms (AAAs), according to new data…
The FDA has authorized marketing of the first laser-based device for removing inferior vena cava (IVC) filters.
The device in question, the Philips CavaClear Laser Sheath, was designed to help…
Rivaroxaban has been approved by the FDA as a treatment for venous thromboembolism (VTE) and thromboprophylaxis among pediatric patients.
The VTE indication is focused on patients under the age of 18…
The CDC has updated its COVID-19 vaccine recommendations for adults, announcing that vaccines developed by Moderna or Pfizer/BioNTech are preferred over the one developed by Johnson & Johnson.
…
Patients treated with transcatheter aortic valve replacement (TAVR) and a peripheral vascular intervention during the same hospitalization…
Conavi Medical, a Toronto-based healthcare company focused on cardiac imaging solutions, has entered agreements to receive more than $20 million in new funding. The money is expected to go toward expanding and boosting…
Bypass surgery is associated with a lower reintervention rate than endovascular therapy among patients with premature peripheral artery disease (PAD) and advanced femoropopliteal disease, according to new findings published in the…
Women face an increased risk of presenting with nonfocal symptoms during acute stroke or transient ischemic attack, according to a new study published in Stroke.
Researchers examined 582,844…
The American College of Cardiology (ACC) and American Heart Association (AHA), through a collaboration with the Society for Cardiovascular Angiography and Interventions, have published a new guidance focused on coronary artery…
Blood clots are common in the hearts of patients who die from COVID-19, researchers confirmed in a new analysis. However, the group noted, the changes expected to be seen in the…
Researchers have uncovered a new treatment that may be able to reduce vascular lesions caused by atherosclerosis, sharing their findings in the …
Thoracic endovascular aortic repair (TEVAR) procedures performed at low-volume hospitals (LVH) are not associated with worse outcomes than those performed at high-volume hospitals (HVH), according to a new study published in the …
Patients with cardiac amyloidosis presenting with heart failure and new-onset atrial fibrillation (AFib) may benefit from direct oral anticoagulants (DOACs) more than vitamin K antagonists (VKAs), according to new data published in…